114 related articles for article (PubMed ID: 7571023)
61. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
[TBL] [Abstract][Full Text] [Related]
62. 99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma.
Bushnell DL; Menda Y; Madsen MT; Link BK; Kahn D; Truhlar SM; Juweid M; Shannon M; Murguia JS
Nucl Med Commun; 2004 Aug; 25(8):839-43. PubMed ID: 15266180
[TBL] [Abstract][Full Text] [Related]
63. Malignant splenic lymphoma: sonographic patterns, diagnosis and follow-up.
Gorg C; Weide R; Schwerk WB
Clin Radiol; 1997 Jul; 52(7):535-40. PubMed ID: 9240707
[TBL] [Abstract][Full Text] [Related]
64. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
65. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
[TBL] [Abstract][Full Text] [Related]
66. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
Zollars LE; Nagel JS; Tumeh SS
J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
[TBL] [Abstract][Full Text] [Related]
67. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
68. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
69. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
70. 18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
[TBL] [Abstract][Full Text] [Related]
71. Use of technetium antigranulocyte monoclonal antibody Fab' fragments for the detection of osteomyelitis.
Harwood SJ; Camblin JG; Hakki S; Morrissey MA; Laven DL; Zangara LM; Patel JU; Webster WB; Carroll RG
Cell Biophys; 1994; 24-25():99-107. PubMed ID: 7736546
[TBL] [Abstract][Full Text] [Related]
72. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
[TBL] [Abstract][Full Text] [Related]
73. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
[TBL] [Abstract][Full Text] [Related]
74. Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Gerrits CJ; van Overhagen H; van Lom K; Adriaansen HJ; Löwenberg B
Br J Haematol; 1994 Nov; 88(3):626-8. PubMed ID: 7819079
[TBL] [Abstract][Full Text] [Related]
75. A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.
Scheinberg DA; Straus DJ; Yeh SD; Divgi C; Garin-Chesa P; Graham M; Pentlow K; Coit D; Oettgen HF; Old LJ
J Clin Oncol; 1990 May; 8(5):792-803. PubMed ID: 2332769
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
Zhang Q; Tian T; Wang L; Qiu H; Li D
Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
[TBL] [Abstract][Full Text] [Related]
77. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
78. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
[TBL] [Abstract][Full Text] [Related]
79. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
80. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
Lugtenburg PJ; Löwenberg B; Valkema R; Oei HY; Lamberts SW; Eijkemans MJ; van Putten WL; Krenning EP
J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
